Lyfe Capital Closes $298M Debut China Healthcare Fund

This Data Is Locked!

This area is available only to Subscribers.

Lyfe Capital, a Chinese healthcare-focused private equity firm, has closed its debut fund at US$298 million to make early-stage equity investments in the the pharmaceuticals,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?